Androgenemic Phenotype Predicts Metabolic Disease and Androgen Burden in Polycystic Ovary Syndrome

Ítems similars

• Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
  per: O'Reilly, M, et al.
  Publicat: (2014)
• Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
  per: Punith Kempegowda, et al.
  Publicat: (2020-06-01)
• AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome
  per: O'Reilly, M, et al.
  Publicat: (2017)
• Urinary Glucocorticoid Metabolite Excretion is Associated with Insulin Resistance Independent of BMI in Patients with Polycystic Ovary Syndrome
  per: O'Reilly, M, et al.
  Publicat: (2012)
• Relationship between Androgen and Glucose Metabolism in Patients with Polycystic Ovary Syndrome
  per: WENG Ruiwen, LIU Yi, ZHANG Wei, LIU Hengwei
  Publicat: (2022-11-01)